We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare Products Regulatory agency provides advice for producers of E-cigarette/vape products
Labelling requirements for e-liquids.
Information for manufacturers and users of medical devices containing plastic with DEHP phthalates.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
Our Patient Involvement Strategy sets out how we will engage and involve the public and patients at every step of the regulatory journey.
Poster with advice for healthcare professionals on how to carry out point of care testing safely and correctly.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
A series of webinars providing guidance on the Windsor Framework agreement and the supply of medicines in Northern Ireland.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Industry must notify the MHRA if they will not be using these flexibilities
Applying for market authorisation for plasma master files (PMFs) and vaccine antigen master files (VAMFs).
Which submission type to select when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Guidance and specifications for the recording and extraction of CTAD data from laboratories in England processing LA and NHS commissioned chlamydia tests.
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Information on how the ACBS factors in the issue of pricing, when reviewing product applications.
How to best protect patients and volunteers during magnetic resonance imaging (MRI) examinations.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).